Skip to main content
MORE PROTECTION

FDA Authorizes a Fourth COVID Vaccine as New Variant Surges

The vaccine uses more traditional technology than other COVID-19 shots, which may convince some unvaccinated Americans to finally get jabbed.

novavax_izmzzn

Matt McClain/Getty Images

By Alice Tecotzky

On Wednesday, the FDA approved Novavax’s COVID-19 vaccine for emergency use, making it the fourth shot available in the country, The Hill reported. Novavax’s shot, which requires two doses three weeks apart, is available for Americans 18 and older, and may appeal to unvaccinated adults since it was manufactured with more traditional technology than other available vaccines. The authorization comes as the White House pushes for more vaccination—as of now, about 77 percent of adults have gotten two doses—to protect against the highly contagious, increasingly dominant new BA.5 variant. Novavax’s shot is currently used in 170 other nations.

Read it at The Hill

TRENDING NOW